Pilot Study Could Improve Treatment of Chronic Diabetic Foot Ulcers
Summary: A pilot study evaluated the GPP@ZnBG hydrogel—a self-regulating bioactive glass-embedded system—for chronic diabetic foot ulcers. The hydrogel dynamically responds to wound pH and glucose/oxidative stress: early alkaline conditions trigger controlled zinc ion release for antibacterial effects, while later degradation releases zinc, calcium, and silicate ions to promote angiogenesis and tissue repair. In the clinical pilot, treated ulcers showed a 94.57% relative reduction in wound surface area within 4 weeks. This active nanotechnology approach addresses persistent infection, inflammation, and impaired healing better than passive standard care and highlights pharmacists’ role in advanced product selection and patient education.
Key Highlights:
- 94.57% wound area reduction in 4 weeks for chronic DFU
- pH-responsive zinc delivery: antibacterial early, pro-angiogenic later
- Addresses biofilm, ROS, and poor perfusion in diabetic wounds
- Study authors: Zhao L, Chen S, Chen S, et al.
Keywords: DFU hydrogel, bioactive glass wound care, chronic diabetic foot ulcer, zinc ion therapy